Insulin stimulates the transcription of the sterol regulatoryelement binding protein (SREBP) 1\ADD1 gene in liver. Hepatocytes in primary culture were used to delineate the insulin signalling pathway for induction of SREBP1 gene expression. The inhibitors of phosphoinositide 3-kinase (PI 3-kinase), wortmannin and LY 294002, abolished the insulin-dependent increase in SREBP1 mRNA, whereas the inhibitor of the mitogenactivated protein kinase cascade, PD 98059, was without effect. To investigate the role of protein kinase B (PKB)\cAkt downstream of PI 3-kinase, hepatocytes were transduced with an adenovirus encoding a PKB-oestrogen receptor fusion protein.
INTRODUCTION
The sterol regulatory-element binding proteins (SREBPs) are microsomal proteins which serve as precursors to transcriptional activators of the basic helix-loop-helix leucine zipper family. In mammals, two distinct genes termed SREBP1 [or adipocyte determination and differentiation factor 1 (ADD1)] and SREBP2 have been identified [1] [2] [3] . The SREBP1 gene is transcribed from optional promoters, giving rise to two mRNAs encoding precursors for SREBP1a and SREBP1c respectively [1] . The Nterminal moiety of each SREBP form, which harbours the transactivation and basic helix-loop-helix leucine zipper DNAbinding domains, is released from the full-length precursor by a two-step proteolytic cleavage, and is imported into the nucleus to activate the transcription of specific genes. The cleavage process is known to be activated when intracellular level of sterols are low, and inhibited when levels are high [4] .
The three forms of SREBP bind cis-acting elements of the SRE or E-box types [5] , and are collectively involved in the transcriptional regulation of genes, encoding the low-density lipoprotein receptor and key enzymes of cholesterol and triacylglycerol biosynthesis [4] . Enzymes of fatty acid synthesis such as acetyl-CoA carboxylase and fatty acid synthase appear to be preferentially regulated by the products of the SREBP1 gene, in particular by SREBP1c in liver and adipose tissue [6, 7] . This factor might also be a critical transcriptional activator of the gene for the regulatory enzyme of hepatic glucose metabolism, glucokinase [8] .
Because glucokinase and the enzymes of triacylglycerol synthesis are inducible, the question arose whether SREBP1 gene Abbreviations used : SREBP, sterol regulatory-element binding protein ; ADD1, adipocyte determination and differentiation factor 1 ; OHT, 4-hydroxytamoxifen ; PI 3-kinase, phosphoinositide 3-kinase ; PKB, protein kinase B or cAkt ; MER, myristoylated Akt∆4-129-oestrogen receptor or myrAkt∆4-129-ER ; A2ER, A2myrAkt∆4-129-ER ; HA, haemagglutinin. 1 To whom correspondence should be addressed (e-mail iynedjian!medecine.unige.ch).
insulin. The addition of OHT to transduced hepatocytes resulted in accumulation of SREBP1 mRNA, with a time-course and magnitude similar to the effect of insulin in non-transduced cells. The level of SREBP1 mRNA was not increased by OHT in hepatocytes expressing a mutant form of the recombinant protein whose PKB activity was not activated by OHT. Thus acute activation of PKB is sufficient to induce SREBP1 mRNA accumulation in primary hepatocytes, and might be the major signalling event by which insulin induces SREBP1 gene expression in the liver.
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expression might itself be hormonally regulated. Indeed, insulin was recently shown to stimulate the accumulation of SREBP1 mRNA in adipocytes and hepatocytes [7, 9] . The present study addresses the mechanism of insulin signalling for induction of SREBP1 gene expression in hepatocytes. The effects of inhibitors of individual signal transduction pathways are reported. In addition, the specific role of protein kinase B (PKB)\cAkt, a protein kinase critically involved in the metabolic actions of insulin [10, 11] , is analysed in cultured hepatocytes transduced with an adenovirus vector encoding a conditionally active form of PKB.
EXPERIMENTAL Hepatocyte culture and transduction with adenovirus
Hepatocytes were isolated and cultured as described previously [12] , except that the dexamethasone concentration in the medium was reduced to 10 −) M. Transduction with adenoviral vectors was performed 4 h after placing cells in culture. The hepatocytes, in 10-cm dishes, were exposed to recombinant viruses in 3 ml of culture medium for 1 h. The medium was removed and the hepatocytes were cultured in 10 ml of virus-free medium for 15 h. The culture medium was replaced once more and the desired effectors were supplied to the cells 2 h after the last medium change. Inhibitors were supplied to cells 30 min before insulin, and in the case of wortmannin again at 2 h and 4 h after insulin. Cells were harvested at specified times after effector addition for isolation of total RNA as described [12] .
Adenovirus vectors
Recombinant DNA fragments encoding the fusion proteins myrAkt∆4-129-ER (MER) and A2myrAkt∆4-129-ER (A2ER) were isolated by BamHI\SalI digestion of pWZLneo retroviral vector plasmids, generously provided by Dr Richard A. Roth (Department of Molecular Pharmacology, Stanford University School of Medicine, Stanford, CA, U.S.A.) [13] . After bluntending with the Klenow enzyme, the fragments were inserted into SwaI site of the cosmid pAdexCAG [14] . Adenoviral vectors were produced by in i o homologous recombination in 293 cells. Transfection of these cells was performed as described by Miyake et al. [15] . Cloning, propagation and titration of the desired recombinant viruses were according to published procedures [14, 15] .
Northern-blot assay of mRNAs
Blotting and hybridization with $#P-labelled cDNA probes was performed by described methods [16] . The amounts of probe hybridized to specific RNA bands were quantified by phosphorimaging of the membranes. The rat SREBP1\ADD1 cDNA was kindly made available by Dr Bruce M. Spiegelman (DanaFarber Cancer Institute, Harvard Medical School, Boston, MA, U.S.A.) [2] , and the rat glyceraldehyde 3-phosphate cDNA by Dr Philippe Fort (CRBM-CNRS, Montpellier, France) [17] .
Immunoblotting and immunoprecipitation assays of PKB
For detection of MER and A2ER proteins expressed in virally transduced hepatocytes, total protein extracts were prepared as described previously [18] . Known amounts of protein were resolved by SDS\PAGE in 10 % polyacrylamide separation gels and transferred to nitrocellulose membranes. Immunoblotting was performed using monoclonal antibodies (12CA5 ; Roche Molecular Biochemicals) against the haemagglutinin (HA) tag present in the middle of the recombinant proteins. The protein kinase activity of authentic or recombinant PKB was assayed by immunoprecipitate enzyme assay. Hepatocytes in 10-cm dishes were lysed in 1 ml of cell lysis buffer (New England Biolabs). Precipitation of endogenous PKB was with solid-phase antibodies to PKB (immobilized Akt1G1 monoclonal ; New England Biolabs). Precipitation of the recombinant PKBs was with anti-HA immobilized on Protein A-Sepharose as described by Kohn et al. [10] . Precipitates were resuspended in a kinase assay mixture containing a glycogen synthase kinase (GSK)-3 fusion protein (New England Biolabs) as substrate and nonradioactive ATP. The specific PKB reaction product was detected after SDS\PAGE by immunoblotting with Phospho-GSK-3 (Ser21\9) antibodies (New England Biolabs). Secondary antibodies conjugated with horseradish peroxidase were used for detection and revealed by enhanced chemiluminescence.
RESULTS

Insulin induction of SREBP1 mRNA is suppressed by inhibitors of phosphoinositide 3-kinase (PI 3-kinase)
The kinetics of effect of insulin on hepatic SREBP1 mRNA was studied using primary cultures of rat hepatocytes. As shown in Figure 1(A) , the level of SREBP1 mRNA began to increase at 4 h after hormone addition and plateaued after 24 h of treatment. Mean increases of SREBP1 mRNA were 6-and 20-fold of the starting level at 8 h and 24 h respectively in four separate hepatocyte experiments. The level of SREBP1 mRNA in hepatocytes was investigated 8 h after the addition of insulin to hepatocytes incubated with various inhibitors of insulin signalling pathways ( Figure 1B) . The inhibitor of PI 3-kinase, wortmannin, abolished the inductive effect of insulin. The insulin-dependent increase in SREBP1 mRNA was also suppressed by LY 294002, a structurally distinct inhibitor of PI 3-kinase. In contrast, the response to insulin was essentially unaffected by PD 98059, an inhibitor of mitogen-activated protein kinase activation, and by rapamycin, an inhibitor of the protein kinase mTOR (mammalian target of rapamycin). With the latter inhibitor, the effect of insulin appeared to be slightly diminished, although the difference did not reach statistical significance. However, the absolute levels of SREBP1 mRNA in both the basal and insulin-stimulated states were reduced to approx. 50 % in presence of rapamycin. The inhibitor effects shown in Figure 1 (B) were maximal effects for all of the drugs tested, a point that was verified by dose-response experiments (results not shown).
Expression of a conditionally activatable PKB fusion protein in cultured hepatocytes
The previous results suggested that insulin-dependent induction of SREBP1 required the activation of the PI 3-kinase. The role of PKB, a protein kinase downstream of PI 3-kinase, was investigated next. To this effect, hepatocytes were transduced with an adenoviral vector encoding a conditionally active form of PKB designed by Roth and colleagues [13] . This protein, termed MER (myristoylated Akt∆4-129-oestrogen receptor), is a chimaeric protein made up of a PKB moiety and an oestrogen receptor moiety, with an HA tag inserted to facilitate detection and immunoprecipitation. The expression of MER in transduced hepatocytes was quantified by immunoblotting with anti-HA antibodies (Figure 2A) . Transduction with increasing numbers of viral particles resulted in dose-related expression of a recombinant protein with an apparent M r of 89 000, in agreement with the sequence of MER. This protein was absent both in nontransduced hepatocytes and in control hepatocytes transduced using a lacZ recombinant adenovirus. Staining the latter cells for β-galactosidase activity indicated that the transduction efficiency was 50-80 % at a multiplicity of infection of 4 and 80 % at a multiplicity of infection of 8 (results not shown).
The ability of the synthetic oestrogen 4-hydroxytamoxifen (OHT) to activate the chimaeric PKB was tested by immunoprecipitate kinase assay. The effect of OHT was compared with that of insulin on authentic PKB in non-transduced hepatocytes. As may be seen in Figure 2 (B), hepatocytes transduced with the MER vector and incubated with OHT for 1 h exhibited strong activation of PKB activity of MER immunoprecipitated with anti-HA antibodies. The effect was comparable with the insulin stimulation of authentic PKB precipitated with anti-PKB antibodies in extracts of non-transduced hepatocytes.
For control purposes, hepatocytes were also transduced with a vector encoding a form of the PKB fusion protein termed A2ER, in which the N-terminal myristoylation signal of the fusion protein is inactivated by a Cys-2 Ala mutation [13] . As illustrated in Figure 2(B) , the PKB activity of this protein assayed in anti-HA immunoprecipitates was not affected by incubation of the hepatocytes with OHT. Both the mutated and unaltered fusion proteins were expressed at similar levels, as verified by immunoblotting with anti-HA antibodies (bottom panel). The lack of OHT activation of the A2ER protein is consistent with the earlier results of Kohn et al. [13] .
Induction of SREBP1 gene expression by OHT in hepatocytes expressing MER
The effect of OHT on the level of SREBP1 mRNA in hepatocytes transduced with the MER adenovirus was investigated. A timedependent accumulation of SREBP1 mRNA was noted from 4-24 h after the addition of OHT (0.2 µM), as shown by Northern blotting ( Figure 3A) . The increase in specific mRNA was doserelated between 0.04 µM and 1 µM OHT ( Figure 3B ). Data from three separate experiments ( Figure 3C) showed that OHT at 0.2 µM was as efficacious for SREBP1 induction as a maximal concentration of insulin (3i10 −) M). Importantly, induction of SREBP1 mRNA by OHT was restricted to hepatocytes expressing MER. A similar effect did not take place in nontransduced hepatocytes, or in hepatocytes transduced with the control A2ER adenovirus.
DISCUSSION
Using the run-on assay, Foretz et al. [7] have shown that insulin stimulates the transcription of the SREBP1 gene in rat liver cells. Therefore we infer that the regulation of SREBP1 mRNA in our experiments resulted mostly from regulation at a transcriptional level. The predominant transcript of the SREBP1 gene in liver is by far SREBP1c mRNA, and this form was the major insulinregulated SREBP1 mRNA identified by RNAse protection assay in hepatocytes [19] . On this basis, the effects reported herein most likely pertain to SREBP1c mRNA, although Northern blotting with SREBP cDNA probes actually does not discriminate between the two mRNAs.
The availability of the OHT-activated PKB fusion protein, and the use of adenovirus vectors to perform gene transfer in a very high percentage of primary hepatocytes, has allowed us to investigate the possible role of PKB in hepatic SREBP1 gene expression by a direct approach. The data conclusively establish that acute stimulation of PKB activity in isolated hepatocytes is sufficient to cause an increase in SREBP1 mRNA levels. Nontransduced hepatocytes did not induce SREBP1 mRNA in response to OHT. More importantly, SREBP1 mRNA was not increased in hepatocytes expressing a recombinant PKB refractory to activation by OHT. This provides stringent proof that the accumulation of SREBP mRNA after OHT addition to the hepatocytes expressing MER was specifically due to PKB activation. Furthermore, the effect elicited by OHT in cells expressing MER was similar in time-course and magnitude to the effect of insulin in non-transduced hepatocytes.
The insulin effect on SREBP1 gene expression was virtually unaffected by the MEK inhibitor, PD 98059, and thus does not appear to require activation of the mitogen-activated protein kinase cascade. By contrast, results with wortmannin and LY 294002 clearly implicated the PI 3-kinase signalling pathway. A major consequence of the activation of PI 3-kinase by insulin in many cell types, including hepatocytes, is a stimulation of PKB activity [20,20a] . The collective results of experiments using inhibitors of PI 3-kinase, on the one hand, and conditional activation of PKB, on the other hand, lead us to propose that induction of SREBP1 gene expression in the liver is most likely mediated via the PI 3-kinase\PKB branch of the insulin signalling pathways. Rapamycin, an inhibitor of mTOR, significantly reduced both induced and basal levels of SREBP1 mRNA, such that a strong insulin stimulation was conserved. However, a possible role of mTOR, which was recently shown to be a substrate for PKB [21] , in maintaining basal SREBP1 gene expression would deserve further investigation.
The PI 3-kinase\PKB signalling pathway is thought to be involved in the insulin regulation of several genes, notably the gene for the insulin-like growth-factor binding protein (IGF-BP) 1 [22] . Recently, PKB was shown to phosphorylate several transcriptional activators of the forkhead family, including FKHR, AFX and FKHRL1, in itro and in intact cells. The phosphorylation of specific residues in these factors inhibited their ability to activate transcription of target genes as a result of the sequestration of the phosphorylated factors in the cytoplasm [23] [24] [25] . Thus, the insulin-dependent repression of the IGF-BP1 gene, which harbours a cis-acting element capable of binding FKHR in its promoter, might depend, at least in part, on PKBmediated phosphorylation and inactivation of this forkhead transactivator [22] . However, recent evidence has suggested that additional signals by-passing the PKB pathway might contribute to down-regulate the transactivating potential of FKHR [26] . Similarly, two distinct experimental systems using hepatoma cells have provided data either in favour of or against a critical role of PKB in the negative regulation of the phosphoenolpyruvate carboxykinase gene by insulin [27, 28] .
Evidence for a role of PKB in the positive regulation of specific gene expression by insulin is more limited. Recent publications suggest that GLUT1 and fatty acid synthase might be induced via PKB activation [29, 30] . The transcription factors which might be affected directly or indirectly by PKB and transduce positive effects of insulin on gene expression are currently unknown. With respect to SREBP1 gene expression, the present data strongly suggest that the insulin effect might be mediated by PKB. A proof for this conclusion will require evidence for the abolition of the effect of insulin after complete and specific suppression of PKB activation. Moreover, insulin signalling via several, possibly redundant, pathways remains an intriguing possibility.
